Notice Number: NOT-CA-18-102
Key Dates
Release Date: August 30, 2018
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) will participate, effective immediately, in RFA-ES-18-012, Human Health Exposure Analysis Resource: UnTargeted Exposure Analysis Laboratories (UC2 Clinical Trial Not Allowed).
The following changes have been made in RFA-ES-18-012 under each of the headings (below) to reflect NCI's participation in this funding opportunity announcement (FOA):
Part 1. Overview Information
Components of Participating Organizations
National Cancer Institute (NCI)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.399
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Gary Ellison, Ph.D., M.P.H.
National Cancer Institute
Telephone: 240-276-6783
Email: [email protected]
Financial/Grants Management Contact(s)
Crystal Wolfrey
National Cancer Institute
Telephone: 240-276-6277
Email: [email protected]
Inquiries
Please direct all inquiries to:
Gary Ellison, Ph.D., M.P.H.
National Cancer Institute
Telephone: 240-276-6783
Email: [email protected]